Back to search

Duquesne

REVELATIONS IN THE BLOOD: DETERMINATION OF BIOMARKERS AND ANALYTES

Abstract

dc:description.abstract

Changes in body chemistry have long been utilized as a tool for medical diagnosis. Whether blood panel, toxin level, antigen testing or any of the myriad other tests performed annually, searching for molecules which confer health status is a long-established practice. These tests give physicians more information and allow them to make a more accurate diagnosis, from which appropriate treatment can stem. Awareness of, and the subsequent search for, biomarkers for disease states have grown substantially in the past years as analytical, biochemical, and instrumental techniques have become more precises and powerful. In an era of increasingly personalized medicine, novel techniques are necessary to ensure the accuracy and sensitivity of clinical methodology. Adding to these fields, methods were developed and optimized for the extraction, separation, and quantification of analytes. This work contains several disparate projects with this goal, ranging from the accurate quantification of a biomarker for autism spectrum disorder, methylmalonic acid, on dried blood spots from levels both above and below the limit of detection, detection of a suite of curcuminoids to determine the potential extraction efficiency curcumin from turmeric under an internal review board approved study utilizing patient blood and cerebrospinal fluid samples, and finally detection of lead isotopes in blood samples to determine potential radon exposure. Two novel proofs of concepts were developed utilizing the stable, organic molecule methylmalonic acid: quantitative dried blood spots utilizing isotope dilution mass spectrometry and a novel analytical technique for accurate quantitation below the limits of detection known as Thor’s Hammer Isotope Dilution Mass Spectrometry. These methods are instrumental for the eventual creation of at home test kits to determine the toxification of the patent and their potential response to treatment. Two other projects were the answers to problems brought to the Kingston Research Group by physicians looking for our expertise to answer: the quantitation of curcumin and detection or radon exposure. The radon exposure experiment resulted in a collaboration between the Kingston Laboratory and UPMC hospital system for method development and experimentation. The methods developed in this work have significantly improved analytically upon existing methods and have resulted in unique and unexpected collaborations.

Degree

thesis:*
Name thesis:degree_name
PhD
Level thesis:degree_level
One-year Embargo
Discipline thesis:degree_discipline
Chemistry and Biochemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jamrom, Jeremiah
Contributors dc:contributor
  • H. M. "Skip" Kingston
  • Mihaela Rita Mihailescu
  • Stephanie Wetzel
  • Scott Faber

Subjects

dc:subject × 5

Rights

Language dc:language
English

Identifiers

dc:identifier.*
Repository record dc:identifier
https://dsc.duq.edu/etd/2207

Chain of custody

source
Harvested from
Duquesne
Base URL
dsc.duq.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Jamrom, Jeremiah. REVELATIONS IN THE BLOOD: DETERMINATION OF BIOMARKERS AND ANALYTES. One-year Embargo thesis, https://dsc.duq.edu/etd/2207